Redmile Group, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for RAPT Therapeutics, Inc. (RAPT)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
RAPT
Shares outstanding
141M shares
Disclosed Ownership
13.9M shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 08:02 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 13.9M 0 13.9M /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 13.9M 0 13.9M /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 5.4% 7.56M 0 7.56M /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.